Searching for evidence to support the use of ginger in the prevention of chemotherapy-induced nausea and vomiting

Paolo Bossi, Diego Cortinovis, Maria Cossu Rocca, Fausto Roila, Patrizia Seminara, Alessandra Fabi, Stefania Canova, Elena Verri, Sonia Fatigoni, Alessandro Iannace, Fabio Macchi, Carla Ripamonti

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Patients with cancer frequently use dietary supplementation and herbal therapies to control symptoms of disease and adverse effects of cancer therapy. Despite the widespread use of dietary supplementation and herbal therapies in oncology, robust scientific evidence in this area is lacking. Not only do these products need to be tested in large and well-designed observational or randomized studies, but their manufacturing process must be improved to achieve higher levels of standardization in product quality. Ginger is frequently used to counteract chemotherapy-induced nausea and vomiting (CINV), and some suggestions that it might be effective against CINV come from randomized and/or crossover clinical trials. However, several limitations in the methods of these studies limit their power and generalizability. The authors are conducting a randomized, double-blind study with a large sample size and homogeneous inclusion criteria in order to evaluate the efficacy of a well-standardized ginger extract in reducing nausea in patients with cancer. The widespread use of standardized herbal therapies and natural components among patients requires that scientific and rigorous research strategies are applied in this field to guide the physicians and the patients in safer use.

Original languageEnglish
Pages (from-to)486-488
Number of pages3
JournalJournal of Alternative and Complementary Medicine
Volume22
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Ginger
Phytotherapy
Nausea
Vomiting
Drug Therapy
Dietary Supplements
Neoplasms
Double-Blind Method
Sample Size
Cross-Over Studies
Clinical Trials
Physicians
Research

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Searching for evidence to support the use of ginger in the prevention of chemotherapy-induced nausea and vomiting. / Bossi, Paolo; Cortinovis, Diego; Cossu Rocca, Maria; Roila, Fausto; Seminara, Patrizia; Fabi, Alessandra; Canova, Stefania; Verri, Elena; Fatigoni, Sonia; Iannace, Alessandro; Macchi, Fabio; Ripamonti, Carla.

In: Journal of Alternative and Complementary Medicine, Vol. 22, No. 6, 01.06.2016, p. 486-488.

Research output: Contribution to journalArticle

Bossi, Paolo ; Cortinovis, Diego ; Cossu Rocca, Maria ; Roila, Fausto ; Seminara, Patrizia ; Fabi, Alessandra ; Canova, Stefania ; Verri, Elena ; Fatigoni, Sonia ; Iannace, Alessandro ; Macchi, Fabio ; Ripamonti, Carla. / Searching for evidence to support the use of ginger in the prevention of chemotherapy-induced nausea and vomiting. In: Journal of Alternative and Complementary Medicine. 2016 ; Vol. 22, No. 6. pp. 486-488.
@article{5e808e51915b414c8831ea6140025073,
title = "Searching for evidence to support the use of ginger in the prevention of chemotherapy-induced nausea and vomiting",
abstract = "Patients with cancer frequently use dietary supplementation and herbal therapies to control symptoms of disease and adverse effects of cancer therapy. Despite the widespread use of dietary supplementation and herbal therapies in oncology, robust scientific evidence in this area is lacking. Not only do these products need to be tested in large and well-designed observational or randomized studies, but their manufacturing process must be improved to achieve higher levels of standardization in product quality. Ginger is frequently used to counteract chemotherapy-induced nausea and vomiting (CINV), and some suggestions that it might be effective against CINV come from randomized and/or crossover clinical trials. However, several limitations in the methods of these studies limit their power and generalizability. The authors are conducting a randomized, double-blind study with a large sample size and homogeneous inclusion criteria in order to evaluate the efficacy of a well-standardized ginger extract in reducing nausea in patients with cancer. The widespread use of standardized herbal therapies and natural components among patients requires that scientific and rigorous research strategies are applied in this field to guide the physicians and the patients in safer use.",
author = "Paolo Bossi and Diego Cortinovis and {Cossu Rocca}, Maria and Fausto Roila and Patrizia Seminara and Alessandra Fabi and Stefania Canova and Elena Verri and Sonia Fatigoni and Alessandro Iannace and Fabio Macchi and Carla Ripamonti",
year = "2016",
month = "6",
day = "1",
doi = "10.1089/acm.2015.0315",
language = "English",
volume = "22",
pages = "486--488",
journal = "Journal of Alternative and Complementary Medicine",
issn = "1075-5535",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Searching for evidence to support the use of ginger in the prevention of chemotherapy-induced nausea and vomiting

AU - Bossi, Paolo

AU - Cortinovis, Diego

AU - Cossu Rocca, Maria

AU - Roila, Fausto

AU - Seminara, Patrizia

AU - Fabi, Alessandra

AU - Canova, Stefania

AU - Verri, Elena

AU - Fatigoni, Sonia

AU - Iannace, Alessandro

AU - Macchi, Fabio

AU - Ripamonti, Carla

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Patients with cancer frequently use dietary supplementation and herbal therapies to control symptoms of disease and adverse effects of cancer therapy. Despite the widespread use of dietary supplementation and herbal therapies in oncology, robust scientific evidence in this area is lacking. Not only do these products need to be tested in large and well-designed observational or randomized studies, but their manufacturing process must be improved to achieve higher levels of standardization in product quality. Ginger is frequently used to counteract chemotherapy-induced nausea and vomiting (CINV), and some suggestions that it might be effective against CINV come from randomized and/or crossover clinical trials. However, several limitations in the methods of these studies limit their power and generalizability. The authors are conducting a randomized, double-blind study with a large sample size and homogeneous inclusion criteria in order to evaluate the efficacy of a well-standardized ginger extract in reducing nausea in patients with cancer. The widespread use of standardized herbal therapies and natural components among patients requires that scientific and rigorous research strategies are applied in this field to guide the physicians and the patients in safer use.

AB - Patients with cancer frequently use dietary supplementation and herbal therapies to control symptoms of disease and adverse effects of cancer therapy. Despite the widespread use of dietary supplementation and herbal therapies in oncology, robust scientific evidence in this area is lacking. Not only do these products need to be tested in large and well-designed observational or randomized studies, but their manufacturing process must be improved to achieve higher levels of standardization in product quality. Ginger is frequently used to counteract chemotherapy-induced nausea and vomiting (CINV), and some suggestions that it might be effective against CINV come from randomized and/or crossover clinical trials. However, several limitations in the methods of these studies limit their power and generalizability. The authors are conducting a randomized, double-blind study with a large sample size and homogeneous inclusion criteria in order to evaluate the efficacy of a well-standardized ginger extract in reducing nausea in patients with cancer. The widespread use of standardized herbal therapies and natural components among patients requires that scientific and rigorous research strategies are applied in this field to guide the physicians and the patients in safer use.

UR - http://www.scopus.com/inward/record.url?scp=84975321866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975321866&partnerID=8YFLogxK

U2 - 10.1089/acm.2015.0315

DO - 10.1089/acm.2015.0315

M3 - Article

AN - SCOPUS:84975321866

VL - 22

SP - 486

EP - 488

JO - Journal of Alternative and Complementary Medicine

JF - Journal of Alternative and Complementary Medicine

SN - 1075-5535

IS - 6

ER -